immune checkpoint inhibitor

You have access
Recurrence Risk and Its Impact on Current Treatment Strategies in Early and Locally Advanced NSCLC
CHARLOTTE TEGENBOSCH and KAROLIEN VEKENS

Anticancer Research December 2024, 44 (12) 5495-5500; DOI: https://doi.org/10.21873/anticanres.17375
You have access
Association of Plasma Nestin With Response to Immune Checkpoint Inhibitors Combined With Chemotherapy in Extensive-stage Small-cell Lung Cancer: A Pilot Study
YUTO SUZUKI, KEN MAENO, YUSUKE KAGAWA, KAZUKI SONE, SATOSHI FUKUDA, TAKEHIRO UEMURA, AYAKO MASAKI, SANAE TODA, YUTA MORI, KENSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, TOMOKO TAJIRI, YUTAKA ITO, TETSUYA OGURI and AKIO NIIMI

Anticancer Research November 2024, 44 (11) 5095-5104; DOI: https://doi.org/10.21873/anticanres.17334
Open Access
True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant Pleural Mesothelioma in Japan
KOZO KURIBAYASHI and JUN HIRANO

Anticancer Research October 2024, 44 (10) 4135-4145; DOI: https://doi.org/10.21873/anticanres.17244
You have access
Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer With Bone Metastases
YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SATOSHI KATO, SHINJI MIWA, MIHO OKUDA, ISAO MATSUMOTO, SEIJI YANO and SATORU DEMURA

Anticancer Research October 2024, 44 (10) 4493-4503; DOI: https://doi.org/10.21873/anticanres.17278
Open Access
Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer
HITOSHI HIRAKAWA, TARO IKEGAMI, HIDETOSHI KINJYO, YOSHIKAZU HAYASHI, SHINYA AGENA, TERUYUKI HIGA, SHUNSUKE KONDO, MASATOMO TOYAMA, HIROYUKI MAEDA and MIKIO SUZUKI

Anticancer Research September 2024, 44 (9) 3907-3912; DOI: https://doi.org/10.21873/anticanres.17218
You have access
Advanced Cholangiocarcinoma With High Tumor Mutation Burden Achieving Complete Response to Immune Check Point Inhibitor
HIROHISA OKABE, TOSHIRO MASUDA, HIDETOSHI NITTA, MASAHIRO TOMITA, ASUKA ONO, DAISUKE KURODA, HIDEYUKI KUROKI, MASAHIKO HIROTA, TAIZO HIBI, HIDEO BABA and HIROKI SUGITA

Anticancer Research July 2024, 44 (7) 3199-3203; DOI: https://doi.org/10.21873/anticanres.17135
You have access
DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer
JI EUN SHIN and SEUNG TAE KIM

Anticancer Research May 2024, 44 (5) 2103-2108; DOI: https://doi.org/10.21873/anticanres.17015
You have access
Association Between Serum Magnesium Levels and Outcomes of Atezolizumab in Patients With Metastatic Urothelial Carcinoma
WATARU FUKUOKAYA, KOHEI AKAZAWA and TAKAHIRO KIMURA

Anticancer Research May 2024, 44 (5) 2117-2123; DOI: https://doi.org/10.21873/anticanres.17017
You have access
Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib
KAREN BRÄUTIGAM, TALINA SCHMIDT, MEIKE BAUR, NIKOLAS TAUBER, EMMANUEL N. KONTOMANOLIS, FRANZISKA HEMPTENMACHER, ACHIM RODY and FRANK KÖSTER

Anticancer Research February 2024, 44 (2) 503-510; DOI: https://doi.org/10.21873/anticanres.16838
Open Access
Non-classical Monocytes Enhance the Efficacy of Immune Checkpoint Inhibitors on Colon Cancer in a Syngeneic Mouse Model
TSUBASA GOSHIMA, KATSUAKI IEGUCHI, NOBUYUKI ONISHI, TAKASHI SHIMIZU, DAISUKE TAKAYANAGI, MAKOTO WATANABE, YUKI FUJIMOTO, RYOTARO OHKUMA, RISAKO SUZUKI, TOSHIAKI TSURUI, EMIKO MURA, NANA IRIGUCHI, TOMOYUKI ISHIGURO, MASAHIRO SHIMOKAWA, YUYA HIRASAWA, YUTARO KUBOTA, HIROTSUGU ARIIZUMI, ATSUSHI HORIIKE, KIYOSHI YOSHIMURA, MAYUMI TSUJI, YUJI KIUCHI, SHINICHI KOBAYASHI, JUN FUJISHIRO, ROBERT M. HOFFMAN, TAKUYA TSUNODA and SATOSHI WADA

Anticancer Research January 2024, 44 (1) 23-29; DOI: https://doi.org/10.21873/anticanres.16784

Main menu

User menu

Search

immune checkpoint inhibitor

Pages